Affordable Access

[The effect of rivastigmine on cognitive functions and regional cerebral blood flow in Alzheimer's disease and vascular dementia: follow-up for 2 years].

Authors
Type
Published Article
Journal
Neurologia i neurochirurgia polska
Publication Date
Volume
38
Issue
6
Pages
471–481
Identifiers
PMID: 15654671
Source
Medline
License
Unknown

Abstract

From the investigations carried out it follows that treatment with rivastigmine during 24 months prevents a decrease of rCBF in patients with AD. However, the cognitive functions deteriorate after 24 months.

Statistics

Seen <100 times